Three pharmaceutical manufacturers—Taro Pharmaceuticals USA, Sandoz, and Apotex Corp.—will pay a total of $447.2 million for alleged violations of the False Claims Act “arising from conspiracies to fix the price of various generic drugs,” the Department of Justice announced Friday.
Taro will pay $213.2 million, Sandoz $185 million, and Apotex $49 million. The civil settlements are in addition to criminal penalties assessed upon each company as part of previously entered deferred prosecution agreements with the Antitrust Division to resolve related charges. In those cases, Taro paid $205.6 million, Sandoz $195 million, and Apotex $24.1 million.
